Nuevo
Ver mas grande
Ver mas grande
Multiplex Assay Kit for Suppression Of Tumorigenicity 14 (ST14) ,etc. by FLIA (Flow Luminescence Immunoassay)
CC-LMP657Hu
Producto nuevo
SNC19; HAI; MT-SP1; PRSS14; TADG15; Epithin; Matriptase; Prostamin; Membrane-type serine protease 1; Serine protease 14; Tumor-associated differentially-expressed gene 15
Comprando este producto generará 9 Biopuntos. Su cesta contiene un total 9 Biopuntos puede ser convertido en un Biobonos Descuento 36.00EUR.
Hoja técnica
| Applications | FLIA Kit for Antigen Detection. |
| Detection Range | 0.1-100ng/mL |
| Sensitivity | The minimum detectable dose of this kit is typically less than 0.033 ng/mL |
| Specificity | <p> |
| Research Area | Tumor immunity |
| Organism species | Homo sapiens (Human) |
| Alternative Names | SNC19 |
| Item Name | Suppression Of Tumorigenicity 14 |
| Assay Length | 3h |
| Method | Double-antibody Sandwich |
| Sample Type | tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
| Formato | 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100 |
| Test Principle | Analyte-specific antibodies are pre-coated onto color-coded microparticles. Microparticles, standards, and samples are pipetted into wells and the immobilized antibodies bind the analytes of interest. After washing away any unbound substances, a biotinyla |
| Assay procedure summary | 1. Preparation of standards, reagents and samples before the experiment |
| UniProt ID | AAH30532.1 |
Más información
Especificidad:
This assay has high sensitivity and excellent specificity for detection of Suppression Of Tumorigenicity 14 (ST14) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Suppression Of Tumorigenicity 14 (ST14) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.